ZJYL (Jin Medical International) Other Stockholders Equity: $0.00 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ZJYL Jin Medical International Ltd ZJYL
63 GF Score
Price $1.94
GF Value $14.58
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Jin Medical International Other Stockholders Equity?

Jin Medical International ZJYL 63 Other Stockholders Equity is $0.00 Mil as of Sep. 2025. GuruFocus rates ZJYL with a GF Score™ of 63/100 and a GF Value™ of $14.58 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Jin Medical International's Other Stockholders Equity for the quarter that ended in Sep. 2025 was $0.00 Mil.

Jin Medical International's quarterly Other Stockholders Equity declined from Sep. 2024 ($0.00 Mil) to Mar. 2025 ($-0.00 Mil) but then increased from Mar. 2025 ($-0.00 Mil) to Sep. 2025 ($0.00 Mil).

Jin Medical International's annual Other Stockholders Equity increased from Sep. 2023 ($-0.00 Mil) to Sep. 2024 ($0.00 Mil) but then declined from Sep. 2024 ($0.00 Mil) to Sep. 2025 ($0.00 Mil).

Jin Medical International Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Jin Medical International's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jin Medical International Other Stockholders Equity Chart

Jin Medical International Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Stockholders Equity
Get a 7-Day Free Trial -0.00 0.00 -0.00 0.00 0.00

Jin Medical International Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 0.00 -0.00 0.00
ZJYL
63GF Score
Jin Medical International Ltd ZJYL
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jin Medical International Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.00 Mil mean?
Jin Medical International (ZJYL) has a Other Stockholders Equity of $0.00 Mil as of Sep. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Jin Medical International and its competitors.
Is Jin Medical International's Other Stockholders Equity too high?
Jin Medical International's current Other Stockholders Equity is $0.00 Mil. Overall, Jin Medical International has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jin Medical International's Other Stockholders Equity compare to RVP and CUPR?
Jin Medical International's Other Stockholders Equity of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Jin Medical International and its competitors. Jin Medical International's current Other Stockholders Equity is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jin Medical International stock overvalued right now?
Based on GuruFocus' analysis, Jin Medical International (ZJYL) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.58, compared to a current price of $1.94 — trading 86.7% below its estimated fair value. The current Other Stockholders Equity is $0.00 Mil. Jin Medical International's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Jin Medical International (ZJYL), the current Other Stockholders Equity is $0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jin Medical International (ZJYL) Overvalued in 2026?

Based on GuruFocus' analysis, Jin Medical International stock appears to be undervalued. The current stock price of $1.94 is trading 86.7% below its estimated GF Value™ of $14.58. GuruFocus considers Jin Medical International to be Significantly Undervalued.

Key valuation signals for ZJYL:

  • Other Stockholders Equity: $0.00 Mil
  • GF Value™: $14.58 vs. price of $1.94 (86.7% below fair value)
  • GF Score™: 63/100 with 7 warning signs

No single metric tells the full story. See the ZJYL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jin Medical International Business Description

Address No. 33 Lingxiang Road, Wujin District, Jiangsu Province, Changzhou, CHN
Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.
63GF Score

Get the complete analysis for ZJYL

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.94
Price
$14.58
GF Value